{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2017", "item": "https://www.patentleaderboard.com/2017/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2017/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Christopher John O'Donnell", "item": "https://www.patentleaderboard.com/2017/inventor/fl:ch_ln:o'donnell-8"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
CO

Christopher John O'Donnell — 2 Patents in 2017

Pfizer: 2 patents #50 of 344Top 15%
Mystic, CT: #4 of 24 inventorsTop 20%
Connecticut: #645 of 3,711 inventorsTop 20%
Overall (2017): #163,208 of 506,227Top 35%
2 Patents 2017

Issued Patents 2017

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9764040 Spliceostatin analogs and methods for their preparation Chakrapani Subramanyam, Frank Koehn, Kenneth John Dirico, Alessandra S. Eustaquio, Michael Eric Green +6 more 2017-09-19 $381,523,000
9751877 Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders Martin Youngjin Pettersson, Douglas Scott Johnson, Chakrapani Subramanyam, Christopher William am Ende, Michael Eric Green +6 more 2017-09-05 $172,618,000